The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma

Background: : Pancreatic adenocarcinoma (PDAC), with more than 250,000 deaths each year, is the eighth leading cause of death worldwide, with a five-year survival of less than 5% and a median recurrence time between 5 and 23 months. The association between PDAC and CD3+/CD8+ tumor-infiltrating lymph...

Descripción completa

Detalles Bibliográficos

Autores principales:	Mahshid Panahi, Fereshteh Rezagholizadeh, Shabnam Mollazadehghomi, Pooya Farhangnia, Mohammad Hadi Karbalaie Niya, Hossein Ajdarkosh, Fahimeh Safarnezhad Tameshkel, Seyed Mohammad Heshmati
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2023-01-01
Colección:	Cancer Treatment and Research Communications
Materias:	Tumor-infiltrating lymphocyte TIL PDAC Pancreatic ductal adenocarcinoma CD8+ TIL
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2468294223000205
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!